公募机构开年火速布局港股市场

Group 1 - The Hong Kong stock market has become a key focus for public fund institutions since 2026, with 27 Hong Kong-themed funds reported as of January 28, focusing on technology, pharmaceuticals, and cyclical sectors [1][2] - Major public fund institutions are leading the way in new product applications, with notable submissions from Guangfa Fund (4 products), and others like Fuguo Fund and Huatai-PineBridge Fund submitting 2 products each [1] - The technology sector remains a primary focus, with various funds targeting technology assets, including actively managed and index-based products, indicating sustained optimism from public institutions [1][2] Group 2 - The pharmaceutical investment scope has broadened, with new products covering not only innovative drugs but also medical devices and services, reflecting a comprehensive approach to the healthcare industry [1] - The cyclical sector is gaining attention from public fund institutions, with new funds targeting traditional industries such as non-ferrous metals and energy, driven by rising resource prices [2] - There is a trend of continuous capital inflow into the Hong Kong stock market, with significant growth in the scale of Hong Kong-themed ETFs, exemplified by the Fuguo CSI Hong Kong Stock Connect Internet ETF reaching a scale of 910.07 billion yuan [2] Group 3 - Different fund managers have varying focuses on investment opportunities in the Hong Kong market, with some emphasizing AI developments and their potential impact on both A-shares and Hong Kong tech leaders [3] - Other fund managers highlight the attractiveness of the adjusted price levels in the Hong Kong medical sector, particularly in innovative drugs, while maintaining a high allocation to the internet sector [3]